Sleep in Congestive Heart Failure

Medical Clinics of North America

Volumn 94, Issue 3, 2010, Pages 447-464

  Sharma, Bhavneesh ^a   Owens, Robert ^a   Malhotra, Atul ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cheyne Stokes respiration; Congestive heart failure; Positive airway pressure therapy; Sleep apnea

Indexed keywords

ACETAZOLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARBON DIOXIDE; CARVEDILOL; THEOPHYLLINE;

APNEA HYPOPNEA INDEX; BEDTIME DOSAGE; CARDIAC RESYNCHRONIZATION THERAPY; CENTRAL SLEEP APNEA SYNDROME; CHEYNE STOKES BREATHING; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DAYTIME SOMNOLENCE; DRUG BLOOD LEVEL; EPWORTH SLEEPINESS SCALE; HEART ASSIST DEVICE; HEART ATRIUM PACING; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; OBESITY; OXYGEN THERAPY; PAROXYSMAL DYSPNEA; PATHOPHYSIOLOGY; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SINUS BRADYCARDIA; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SNORING;

HEART FAILURE; HUMANS; NOCTURNAL MYOCLONUS SYNDROME; POLYSOMNOGRAPHY; PREVALENCE; SLEEP APNEA SYNDROMES; SLEEP APNEA, CENTRAL; SLEEP APNEA, OBSTRUCTIVE;

EID: 77951753458     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.02.009     Document Type: Review

References (100)

1. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 104 24 (2001) 2996-3007
2. Levy D., Kenechaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 18 (2002) 1397-1402
3. Javaheri S., Parker T.J., Liming J.D., et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97 21 (1998) 2154-2159
4. Tremel F., Pépin J.L., Veale D., et al. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 20 16 (1999) 1201-1209
5. Sin D.D., Fitzgerald F., Parker J.D., et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160 4 (1999) 1101-1106
6. Punjabi N.M. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5 2 (2008) 136-143
7. Solin P., Kaye D.M., Little P.J., et al. Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 123 4 (2003) 1119-1126
8. Lanfranchi P.A., Braghiroli A., Bosimini E., et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 99 11 (1999) 1435-1440
9. Oldenburg O., Lamp B., Faber L., et al. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9 3 (2007) 251-257
10. Yumino D., Wang H., Floras J.S., et al. Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail 15 4 (2009) 279-285
11. Schulz R., Blau A., Börgel J., et al. Sleep apnoea in heart failure. Eur Respir J 29 6 (2007) 1201-1205
12. Padeletti M., Green P., Mooney A.M., et al. Sleep disordered breathing in patients with acutely decompensated heart failure. Sleep Med 10 3 (2009) 353-360
13. MacDonald M., Fang J., Pittman S.D., et al. The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers. J Clin Sleep Med 4 1 (2008) 38-42
14. Chan J., Sanderson J., Chan W., et al. Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 111 6 (1997) 1488-1493
15. Findley L.J., Zwillich C.W., Ancoli-Israel S., et al. Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure. South Med J 78 1 (1985) 11-15
16. Bradley T.D. Crossing the threshold: implications central sleep apnea. Am J Respir Crit Care Med 165 9 (2002) 1203-1204
17. Javaheri S. Acetazolamide improves central sleep apnea in congestive heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 173 2 (2006) 234-237
18. Solin P., Roebuck T., Johns D.P., et al. Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med 162 6 (2000) 2194-2200
19. Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 341 13 (1999) 949-954
20. Solin P., Bergin P., Richardson M., et al. Influence of pulmonary capillary wedge pressure on central sleep apnea in heart failure. Circulation 99 12 (1999) 1574-1579
21. Lorenzi-Filho G., Azevedo E.R., Parker J.D., et al. Relationship of carbon dioxide tension in arterial blood to pulmonary wedge pressure in heart failure. Eur Respir J 19 1 (2002) 37-40
22. Paintal A.S. Vagal sensory receptors and their reflex effects. Physiol Rev 53 1 (1973) 159-227
23. Oldenburg O., Bitter T., Wiemer M., et al. Pulmonary capillary wedge pressure and pulmonary arterial pressure in heart failure patients with sleep-disordered breathing. Sleep Med 10 7 (2009) 726-730
24. Xie A., Skatrud J.B., Khayat R., et al. Cerebrovascular response to carbon dioxide in patients with congestive heart failure. Am J Respir Crit Care Med 165 3 (2002) 371-378
25. Dowdell W.T., Javaheri S., and McGinnis W. Cheyne-Stokes respiration presenting a sleep apnea syndrome: clinical and polysomnographic features. Am Rev Respir Dis 141 4 Pt 1 (1990) 871-879
26. Badr S., Toiber F., Skatrud J., et al. Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol 78 5 (1995) 1806-1815
27. Bucca C.B., Brussino L., Battisti A., et al. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 132 2 (2007) 440-446
28. Johns M.W. A new method for measuring daytime sleepiness: the Epsworth sleepiness scale. Sleep 14 6 (1991) 540-545
29. Netzer N.C., Stoohs R.A., Netzer C.M., et al. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131 7 (1999) 485-491
30. Maislin G., Pack A.I., Kribbs N.B., et al. A survey screen for prediction of apnea. Sleep 18 3 (1995) 158-166
31. Chesson Jr. A.L., Berry R.B., and Pack A. Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep 26 7 (2003) 907-913
32. American Thoracic Society/American College of Chest Physicians/American Academy of Sleep medicine Taskforce Steering Committee. Executive summary on the systematic review and practice parameters for portable monitoring in the investigation of suspected sleep apnea in adults. Am J Respir Crit Care Med 169 10 (2004) 1160-1163
33. Sériès F., Kimoff R.J., Morrison D., et al. Prospective evaluation of nocturnal oximetry for detection of sleep-related breathing disturbances in patients with chronic heart failure. Chest 127 5 (2005) 1507-1514
34. Mortara A., Pinna G.D., Johnson P., et al. Home telemonitoring in heart failure patients: the HHH study (Home or Hospital in Heart Failure). Eur J Heart Fail 11 3 (2009) 312-318
35. Tateishi O., Shouda T., Sakai T., et al. Apnea-related heart rate variability in congestive heart failure patients. Clin Exp Hypertens 25 3 (2003) 183-189
36. Yasuda Y., Umezu A., Horihata S., et al. Modified thoracic impedance plethysmography to monitor sleep apnea syndromes. Sleep Med 6 3 (2005) 215-224
37. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 101 4 (2000) 392-397
38. Leung R.S., Diep T.M., Bowman M.E., et al. Provocation of ventricular ectopy by Cheyne-Stokes respiration in patients with heart failure. Sleep 27 7 (2004) 1337-1343
39. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 106 1 (2006) 21-28
40. Carmona-Bernal C., Ruiz-García A., Villa-Gil M., et al. Quality of life in patients with congestive heart failure and central sleep apnea. Sleep Med 9 6 (2008) 646-651
41. Javaheri S., Shukla R., Zeigler H., et al. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 49 20 (2007) 2028-2034
42. Luo Q., Zhang H.L., Tao X.C., et al. Impact of untreated sleep apnea on prognosis of patients with congestive heart failure. Int J Cardiol (2009) [Epub ahead of print]
43. Bradley T.D., Hall M.J., Ando S., et al. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest 119 6 (2001) 1827-1835
44. Shahar E., Whitney C.W., Redline S., et al. Sleep disordered breathing and cardiovascular disease: cross-sectional results of The Sleep Heart Health Study. Am J Respir Crit Care Med 163 1 (2001) 19-25
45. Arias M.A., García-Río F., Alonso-Fernández A., et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 112 3 (2005) 375-383
46. Somers V.K., Dyken M.E., Clary M.P., et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 4 (1995) 1897-1904
47. Nieto F.J., Young T.B., Lind B.K., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 283 14 (2000) 1829-1836
48. Butt M., Dwivedi G., Khair O., et al. Obstructive sleep apnea and cardiovascular disease. Int J Cardiol 139 1 (2010) 7-16
49. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105 21 (2002) 2462-2464
50. Schulz R., Mahmoudi S., Hattar K., et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162 2 Pt 1 (2000) 566-570
51. Walsh J.T., Andrews R., Starling R., et al. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J 73 3 (1995) 237-241
52. Tamura A., Kawano Y., Kadota J., et al. Carvedilol reduces the severity of central sleep apnea in chronic heart failure. Circ J 73 2 (2009) 295-298
53. Tamura A., Kawano Y., Naono S., et al. Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 131 1 (2007) 130-135
54. Eskafi M., Cline C., Nilner M., et al. Treatment of sleep apnea in congestive heart failure with a dental device: the effect on brain natriuretic peptide and quality of life. Sleep Breath 10 2 (2006) 90-97
55. Johnson C.B., Beanlands R.S., Yoshinaga K., et al. Acute and chronic effects of continuous positive airway pressure therapy on left ventricular systolic and diastolic function in patients with obstructive sleep apnea and congestive heart failure. Can J Cardiol 24 9 (2008) 697-704
56. Egea C.J., Aizpuru F., Pinto J.A., et al. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study. Sleep Med 9 6 (2008) 660-666
57. Mansfield D.R., Gollogly N.C., Kaye D.M., et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169 3 (2004) 361-366
58. Kaneko Y., Floras J.S., Usui K., et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348 13 (2003) 1233-1241
59. Tkacova R., Rankin F., Fitzgerald F.S., et al. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 98 21 (1998) 2269-2275
60. Smith L.A., Vennelle M., Gardner R.S., et al. Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. Eur Heart J 28 10 (2007) 1221-1227
61. Sharma B., Karbowitz S., and Feinsilver S. A meta-analysis of randomized controlled trials evaluating the effect of nocturnal continuous airway pressure (CPAP) therapy on ejection fraction in patients with systolic congestive heart failure and obstructive sleep apnea. Sleep 32 (2009) A175
62. Khayat R.N., Abraham W.T., Patt B., et al. In-hospital treatment of obstructive sleep apnea during decompensation of heart failure. Chest 134 4 (2009) 991-997
63. Krachman S.L., D'Alonzo G.E., Berger T.J., et al. Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration during sleep in congestive heart failure. Chest 116 6 (1999) 1550-1557
64. Yasuma F. [Effects of continuous positive airway pressure on Cheyne-Stokes breathing in congestive heart failure]. Nihon Kokyuki Gakkai Zasshi 40 10 (2002) 801-805 [in Japanese]
65. Sin D.D., Logan A.G., Fitzgerald F.S., et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 102 1 (2000) 61-66
66. Granton J.T., Naughton M.T., Benard D.C., et al. CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 153 1 (1996) 277-282
67. Naughton M.T., Benard D.C., Liu P.P., et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 152 2 (1995) 473-479
68. Bradley T.D., Logan A.G., Kimoff R.J., et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353 19 (2005) 2025-2033
69. 2O for 1 year in five cases. Respiration 72 2 (2005) 198-201
70. Arzt M., Floras J.S., Logan A.G., et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115 25 (2007) 3173-3180
71. Köhnlein T., Welte T., Tan L.B., et al. Assisted ventilation for heart failure patients with Cheyne-Stokes respiration. Eur Respir J 20 4 (2002) 934-941
72. Arzt M., Wensel R., Montalvan S., et al. Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure. Chest 134 1 (2008) 61-66
73. Oldenburg O., Schmidt A., Lamp B., et al. Adaptive servoventilation improves cardiac function in patients with chronic heart failure and Cheyne-Stokes respiration. Eur J Heart Fail 10 6 (2008) 581-586
74. Pepperell J.C., Maskell N.A., Jones D.R., et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 168 9 (2003) 1109-1114
75. Hastings P.C., Vazir A., Meadows G.E., et al. Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study. Int J Cardiol 139 1 (2010) 17-24
76. Teschler H., Döhring J., Wang Y.M., et al. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 164 4 (2001) 614-619
77. Zhang X.L. Treatment of Cheyne Stokes respiration with adaptive servo ventilation and bilevel ventilators in patients with chronic heart failure. Available at:. http://www.ClinicalTrials.gov Identifier: NCT00725595. Accessed December 12, 2009
78. Hetland A. Chronic heart failure-Cheyne Stokes respiration-CS2 (3C-Study). Available at:. http://www.ClinicalTrials.gov Identifier: NCT00563693. Accessed December 12, 2009
79. Teschler H., and Cowie M. Treatment of predominant central sleep apnoea by adaptive servo ventilation in patients with heart failure (Serve-HF). Available at:. http://www.ClinicalTrials.gov Identifier: NCT00733343. Accessed December 12, 2009
80. Staniforth A.D., Kinnear W.J., Starling R., et al. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 19 6 (1998) 922-928
81. Sasayama S., Izumi T., Seino Y., et al. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and Cheyne-Stokes respiration. Circ J 70 1 (2006) 1-7
82. Sasayama S., Izumi T., Matsuzaki M., et al. Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. Circ J 73 7 (2009) 1255-1262
83. Toyama T., Seki R., Kasama S., et al. Effectiveness of nocturnal home oxygen therapy to improve exercise capacity, cardiac function and cardiac sympathetic nerve activity in patients with chronic heart failure and central sleep apnea. Circ J 73 2 (2009) 299-304
84. Andreas S., Bingeli C., Mohacsi P., et al. Nasal oxygen and muscle sympathetic nerve activity in heart failure. Chest 123 2 (2003) 366-371
85. Khayat R.N., Xie A., Patel A.K., et al. Cardiorespiratory effects of added dead space in patients with heart failure and central sleep apnea. Chest 123 5 (2003) 1551-1560
86. Javaheri S., Parker T.J., Wexler L., et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 335 8 (1996) 562-567
87. Cherniack N.S. Sleep apnea and its causes. J Clin Invest 73 6 (1984) 1501-1506
88. Nakayama H., Smith C.A., Rodman J.R., et al. Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. Am J Respir Crit Care Med 165 9 (2002) 1251-1260
89. Garrigue S., Bordier P., Jaïs P., et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 346 6 (2002) 404-412
90. Lüthje L., Unterberg-Buchwald C., Dajani D., et al. Atrial overdrive pacing in patients with sleep apnea with implanted pacemaker. Am J Respir Crit Care Med 172 1 (2005) 118-122
91. Sharafkhaneh A., Sharafkhaneh H., Bredikus A., et al. Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure. Sleep Med 8 1 (2007) 31-36
92. Vazir A., Hastings P.C., Morrell M.J., et al. Resolution of central sleep apnoea following implantation of a left ventricular assist device. Int J Cardiol 138 3 (2010) 317-319
93. Sinha A.M., Skobel E.C., Breithardt O.A., et al. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 44 1 (2004) 68-71
94. Skobel E.C., Sinha A.M., Norra C., et al. Effect of cardiac resynchronization therapy on sleep quality, quality of life, and symptomatic depression in patients with chronic heart failure and Cheyne-Stokes respiration. Sleep Breath 9 4 (2005) 159-166
95. Stanchina M.L., Ellison K., Malhotra A., et al. The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot study. Chest 132 2 (2007) 433-439
96. Shalaby A. Impact of resynchronization therapy on sleep disordered breathing in advanced congestive heart failure (IMPACT). Available at:. http://www.ClinicalTrials.gov Identifier: NCT00521534. Accessed December 12, 2009
97. Mansfield D.R., Solin P., Roebuck T., et al. The effect of successful heart transplant treatment of heart failure on central sleep apnea. Chest 124 5 (2003) 1675-1681
98. Javaheri S., Abraham W.T., Brown C., et al. Prevalence of obstructive sleep apnoea and periodic limb movement in 45 subjects with heart transplantation. Eur Heart J 25 3 (2004) 260-266
99. Hanly P.J., and Zuberi-Khokhar N. Periodic limb movements during sleep in patients with congestive heart failure. Chest 109 6 (1996) 1497-1502
100. Skomro R., Silva R., Alves R., et al. The prevalence and significance of periodic leg movements during sleep in patients with congestive heart failure. Sleep Breath 13 1 (2009) 43-47